2. Tumorigenesis and drug resistance: promotes the survival, proliferation and metastasis of tumor cells by activating the NF-κB or MAPK pathway, and leads to such as tumor immune evasion and drug resistance. This evidence concerns the gene NFKB1 and neoplasm.